NCT06558162 The Effect of Two Different Self-Assessment Methods for Fetal Movement Monitoring on Maternal Psychosocial Status
| NCT ID | NCT06558162 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kırklareli University |
| Condition | Fetal Movement |
| Study Type | INTERVENTIONAL |
| Enrollment | 76 participants |
| Start Date | 2024-03-30 |
| Primary Completion | 2024-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 76 participants in total. It began in 2024-03-30 with a primary completion date of 2024-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Antenatal care is essential for a successful delivery, a healthy baby and a happy mother. The main aim of antenatal care is to take appropriate interventions to assess, protect and improve maternal and fetal health during pregnancy. There are many methods to assess fetal health during pregnancy, such as ultrasonography (USG) and non stress test (NST). Along with these methods, maternal perception and counting of fetal movements is the only method that can be easily used by the mother without the need for clinicians or equipment. When a pregnant woman begins to feel fetal movements, it is one of the first signs of fetal life and is considered an indicator of fetal well-being. Decrease or absence of fetal movements has been stated to be an important parameter in the assessment of fetal health and may be associated with the risk of intrauterine fetal death. Therefore, feeling and counting of fetal movements is the basis for the assessment of fetal health.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the research * Over 18 years of age * Single pregnancy * Being between 28-32 weeks of gestation * Primiparity * At least primary school graduation * No diagnosed problems related to the health of the fetus (such as fetal anomaly, intrauterine growth retardation) No risky pregnancy (such as pre-eclampsia, diabetes, heart disease, placenta previa, oligohydramnios) Exclusion Criteria: * Not having any disabilities that may prevent communication (speech, hearing, mental) * No chronic or psychiatric illness * Conception with assisted reproductive techniques
Contact & Investigator
Neriman Güdücü, Dr.
STUDY DIRECTOR
Kırklareli University
Frequently Asked Questions
Who can join the NCT06558162 clinical trial?
This trial is open to female participants only, studying Fetal Movement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06558162 currently recruiting?
Yes, NCT06558162 is actively recruiting participants. Contact the research team at aleynayldz10@gmail.com for enrollment information.
Where is the NCT06558162 trial being conducted?
This trial is being conducted at Kırklareli, Turkey (Türkiye).
Who is sponsoring the NCT06558162 clinical trial?
NCT06558162 is sponsored by Kırklareli University. The principal investigator is Neriman Güdücü, Dr. at Kırklareli University. The trial plans to enroll 76 participants.